For comments, suggestions
Created with Raphaël 2.1.0 09.12.2015 Filing date 17.07.2017 Validation fee payment 31.01.2018 (A1) Patent application published 03.06.2022 AGEPI application filing date 30.09.2022 (T2) Translation of the validated European patent 28.04.2025 09.12.2025 Valid until 10.12.2026 Renewal fee to be paid until 09.12.2035 Patent will expire on

Patent in force


(210)Number of the EPO application15817678
(220)Filing date of the EPO application2015.12.09
(80)EPO patent specification publication (B)EPB nr. 13/2022, 2022.03.30
(110)EPO patent number3233108
(11)Number of the documentMD 3233108 T2
(21)Number of the applicatione 2017 0200
(71)Name(s) of applicant(s), code of the countryELI LILLY AND COMPANY, US;
(72)Name(s) of inventor(s), code of the countryAKERS Michael Patrick, US;
MAJUMDAR Ranajoy, US;
NGUYEN Chi A., US;
PAAVOLA Chad D., US;
SARIN Virender Kumar, US;
SCHULTE Nanette Elizabeth, US;
(73)Name(s) of owner(s), code of the countryELI LILLY AND COMPANY, US;
(54)Title of the inventionRapid-acting insulin compositions
(13)Kind-of-document code T2
(51)International Patent Classification A61K 38/28 (2006.01.01); A61K 47/12 (2006.01.01); A61P 3/10 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2018.01.31
(49)Date of publication of the translation of the validated European patent specification2022.09.30
(30)Priority201462092407 P, 2014.12.16, US
(74)Patent attorney(Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova
(86)International applicationPCT/US2015/064744, 2015.12.09
(87)International publicationWO 2016/100042, 2016.06.23
Up
/Inventions/details/3233108